Coloplast A/S
CSE:COLO B

Watchlist Manager
Coloplast A/S Logo
Coloplast A/S
CSE:COLO B
Watchlist
Price: 786 DKK 0.69% Market Closed
Market Cap: 176.9B DKK
Have any thoughts about
Coloplast A/S?
Write Note

Gross Margin
Coloplast A/S

67.6%
Current
68%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
67.6%
=
Gross Profit
18.3B
/
Revenue
27B

Gross Margin Across Competitors

Country DK
Market Cap 177.1B DKK
Gross Margin
68%
Country JP
Market Cap 7T JPY
Gross Margin
86%
Country CH
Market Cap 38.2B CHF
Gross Margin
55%
Country US
Market Cap 16.3B USD
Gross Margin
70%
Country KR
Market Cap 10.3T KRW
Gross Margin
15%
Country CN
Market Cap 51B CNY
Gross Margin
72%
Country US
Market Cap 6.7B USD
Gross Margin
65%
Country CA
Market Cap 6.3B USD
Gross Margin
61%
Country UK
Market Cap 4.6B GBP
Gross Margin
56%
Country US
Market Cap 5.6B USD
Gross Margin
47%
Country CH
Market Cap 4.7B CHF
Gross Margin
35%
No Stocks Found

Coloplast A/S
Glance View

Economic Moat
None
Market Cap
177.1B DKK
Industry
Health Care

Coloplast A/S, headquartered in Humlebæk, Denmark, has a storied history that dates back to 1954 when a nurse, Elise Sørensen, identified a crucial need in the healthcare sector. Her sister had undergone ostomy surgery, and the lack of appropriate post-operative care products inspired Sørensen to design the world’s first adhesive ostomy bag. This innovation laid the groundwork for Coloplast's trajectory in the healthcare industry. Today, the company has expanded its focus to include ostomy care, continence care, wound and skin care, and interventional urology. With a commitment to improving patients' quality of life, Coloplast has become a leader in designing and manufacturing products that not only highlight practicality but also embody comfort and discretion. Coloplast generates revenue through a business model that emphasizes product innovation and direct engagement with healthcare providers and patients. The company invests significantly in research and development to improve and widen its product offerings continuously. It operates globally, distributing its products directly and via partnerships with hospitals, clinics, and healthcare professionals. By maintaining an attentive approach to user experience and incorporating customer feedback into its development processes, Coloplast ensures its portfolio aligns with the actual needs of its users. This user-centered strategy not only enhances customer loyalty but also fortifies the company’s market position, driving its financial success.

COLO B Intrinsic Value
832.39 DKK
Undervaluation 6%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
67.6%
=
Gross Profit
18.3B
/
Revenue
27B
What is the Gross Margin of Coloplast A/S?

Based on Coloplast A/S's most recent financial statements, the company has Gross Margin of 67.6%.